Get started
Work

Monoclonal Gammopathy of Undetermined Significance and Risk of Chronic Kidney Disease: Results of the Population-Based Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

Year: 2022
Type: article
Study design: Observational Study
Source: Blood
DOI: 10.1182/blood-2022-170623
Authors: Thorir Einarsson Long, Elias Eythorsson, Sæmundur Rögnvaldsson, Olafur Indridason, Runolfur Palsson, Sigrún Thorsteinsdóttir, Ingigerdur S Sverrisdottir, Thor Aspelund, Brynjar Vidarsson, Páll Torfi Onundarson, Bjarni Agnarsson, Margrét Sigurdardóttir, Ingunn Thorsteinsdottir, Ísleifur Ólafsson, Asdis Rosa Thordardottir, Asbjorn Jonsson, Gauti Kjartan Gislason, Andri Olafsson, Hlif Steingrimsdottir, Malin Hultcrantz, Brian G.M. Durie, Stephen Harding, Ola Landgren, Thorvardur Jon Love, Sigurdur Y Kristinsson
Institutions: University of Iceland, National University Hospital of Iceland, Skåne University Hospital, Rigshospitalet, Sahlgrenska University Hospital, Memorial Sloan Kettering Cancer Center, Cedars-Sinai Medical Center, University of Miami, Sylvester Comprehensive Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4310108180
FWCI: 0.182
Cites:
Cited by: 1
Related to: 10